02367 GIANT BIOGENE
Closed Add to Porfolio| Key Financial Ratio (Fiscal Year: 12/2024) | |||
| Current | 7.66X | Oper Margin | 44.4% |
|---|---|---|---|
| LT Debt/Equity | 0.0% | Net Margin | 37.2% |
| Total Debt/Equity | 0.1% | Return on Equity | 29.0% |
| Price/Book | 8.27X | Return on Assets | 25.7% |
| (HKD 60.800) | 2024-12 | 2023-12 | 2022-12 | 2021-12 | 2020-12 |
| Net Profit (MHKD) | 2,193.31 | 1,600.12 | 780.35 | 989.25 | 980.83 |
|---|---|---|---|---|---|
| Net Profit Growth (%) | +37.1 | +105.1 | -21.1 | +0.9 | +58.9 |
| Earnings Per Share (HKD) | 2.234 | 1.639 | 1.11 | 1.015 | 0.981 |
| Earnings Per Share Growth (%) | +36.3 | +47.7 | +9.4 | +3.5 | +58.9 |
| Dividend Per Share (HKD) | 1.306 | 0.970 | No dividend | No dividend | No dividend |
| P/E* (X) | 27.22 | 37.10 | 54.78 | 59.91 | 61.99 |
| Yield (%) | 2.15 | 1.60 | N/A | N/A | N/A |
| Dividend Share (%) | 58.46 | 59.18 | N/A | N/A | N/A |
| Book NAV (HKD) | 7.352 | 4.832 | 3.193 | N/A | N/A |
| Auditors' Opinion | Unqualified | Unqualified | Unqualified | N/A | N/A |
Remarks:
1. Unqualified = Not Qualified because the financial statements have been fairly presented in accordance with appropriate accounting standards and companies ordinance.
2. Unqualified # = Not Qualified in respect of fundamental uncertainty because of appropriate disclosures.
3. Qualified = Qualified Opinion in respect of limitation in audit scope and/or disclaimer on view given by financial statements and/or disagreement of accounting treatment and/or adverse opinion.
1. Unqualified = Not Qualified because the financial statements have been fairly presented in accordance with appropriate accounting standards and companies ordinance.
2. Unqualified # = Not Qualified in respect of fundamental uncertainty because of appropriate disclosures.
3. Qualified = Qualified Opinion in respect of limitation in audit scope and/or disclaimer on view given by financial statements and/or disagreement of accounting treatment and/or adverse opinion.
Last Update Time: 2025-07-22 21:40:20
Latest Result
| (RMBMn) | 2024-12 | 2023-12 | Chg* (%) | 2022-12 |
| Cover Period (mths) | 12 | 12 | NA | 12 |
|---|---|---|---|---|
| Turnover | 5,539 | 3,524 | +57.2 | 2,364 |
| Operating Result | 2,461 | 1,745 | +41.0 | 1,178 |
| Associates | -3.601 | 0 | N/A | 0 |
| Profit Before Taxation | 2,458 | 1,745 | +40.9 | 1,178 |
| Taxation | 396.027 | 296.887 | +33.4 | 176.163 |
| Profit /( Loss) After Taxation | 2,062 | 1,448 | +42.4 | 1,002 |
| Minority Interests | -0.62 | -3.551 | -82.5 | -0.439 |
| Net Profit | 2,062 | 1,452 | +42.0 | 695.998 |
| Earnings Per Share () | 2.2337 | 1.6390 | +36.3 | 1.1098 |
| Dividend Per Share () | 1.3059 | 0.9700 | +34.6 | 0.0000 |
| Announcement Date | 2025-03-26 | 2024-03-25 | NA | 2023-03-27 |
* Annualised
Last Update Time: 2025-07-22 21:40:25
